Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_assertion type Assertion NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_head.
- NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_assertion description "[In this paper, an overview was depicted about the role of following miRNAs in pancreatic development and insulin secretion (miR-375, miR-7, miR-124a2, miR-195, miR-126, miR-9, miR-96, miR-34a); insulingrowth factor-1 receptor expression (miR-7, miR-139, miR-145, miR-1); the diabetes-associated pancreatic cancer pathway genes such as IRS, PI3K, AKT/PKB (miR-128a, miR-19a, miR-21, miR-29 a/b/c); mTOR protein regulation (miR- 99, miR-21, miR-126, and miR-146a) etc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_provenance.
- NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_assertion evidence source_evidence_literature NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_provenance.
- NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_assertion SIO_000772 23834149 NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_provenance.
- NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_assertion wasDerivedFrom befree-2016 NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_provenance.
- NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_assertion wasGeneratedBy ECO_0000203 NP1092134.RAuy7Wd7NoHFwYpB8Qg_j6-UyTA8zzDAwyMPM64VYQuYY130_provenance.